Search
for
Sort by
Research 361–390 of 1000+
- FGF Family: From Drug Development to Clinical Application
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Beta-caryophyllene enhances wound healing through multiple routes
- Cellular actions of testosterone in vascular cells: Mechanism independent of aromatization to estradiol
- Lysophospholipid Mediators in Health and Disease
- 5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Neurosteroids Are Endogenous Neuroprotectants in an Ex Vivo Glaucoma Model
- Novel anticonvulsive effects of progesterone in a mouse model of hippocampal electrical kindling
- Lysophosphatidic acid increases the proliferation and migration of adipose-derived stem cells via the generation of reactive oxygen species
- Bone vs. fat: Embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts
- S100A6 Protein—Expression and Function in Norm and Pathology
- Inhibition of Hair Growth by Testosterone in the Presence of Dermal Papilla Cells from the Frontal Bald Scalp of the Postpubertal Stumptailed Macaque
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- 4 Vitamin D resistance
- Synaptic‐like vesicles and candidate transduction channels in mechanosensory terminals
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Mandibulofacial dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric effects on ligand binding
- Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca<sup>2+</sup> homeostasis
- Viewpoint 6
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Cultivation of Hair Matrix Cells from Cashmere Goat Skins and Exemplified Applications
- The incidental pore: Ca<sub>V</sub>1.2 and stem cell activation in quiescent hair follicles
- Key Factors in the Complex and Coordinated Network of Skin Keratinization: Their Significance and Involvement in Common Skin Conditions
- Case report: A pregnant woman accidental treated with spironolactone in mid-gestation